Fixed Low-dose Eltrombopag and rhTPO for Immune Thrombocytopenia (FLOWER)
Clinical trial NCT04518878 · UNKNOWN
Trial details
- NCT number
- NCT04518878
- Sponsor
- Peking University People's Hospital
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-31
- Primary completion
- 2021-12-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.